Merck & Co Inc

NYSE: MRK
$96.31
-$2.05 (-2.1%)
Closing Price on November 15, 2024

MRK Articles

thinkstockJune 12, 2015: Markets opened lower on Friday as a solution to the Greek-European Union seems to draw further away from negotiators. Energy and healthcare stocks both opened weak and were...
The May 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest is down.
Credit Suisse has updated its autoimmune market model and it sees implications for all of the large cap U.S. pharmaceutical companies in its coverage.
thinkstockJune 2, 2015: Markets opened lower on Tuesday as a settlement of the Greek financial problem continues to evade negotiators. The euro rose today, sending the dollar lower and the yield on...
The short interest data has been released for the May 15 settlement date and for the selected pharmaceutical stocks, short interest is mixed.
thinkstockMay 22 2015: Markets opened mixed on Friday on a day that was tough on blue chips. The energy sector slipped on a stronger dollar and lower crude oil prices, even though crude posted a...
The April 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest is mixed.
A new research report from Savita Subramanian and her well-regarded team at Merrill Lynch points out that some of the biggest positive surprises have been from the mega-cap stocks.
In a new report, the RBC team focused on the companies that are making the most progress with treatments for patients with breast cancer.
Credit Suisse has released a report that detailed its top picks for pharmaceutical stocks for the rest of 2015.
thinkstockMay 4, 2015: Markets opened higher on Monday after a relatively quiet night overseas. Both U.K. and Japanese equities markets were closed Monday for holidays. Other Asian and European...
thinkstockApril 28, 2015: Markets opened slightly higher on Tuesday but were able to cross back into positive territory on early strength from the tech and healthcare sectors. Equities appear headed...
Merck has managed to beat its first-quarter earnings expectations, and handily at that.
thinkstockApril 27, 2015: Markets opened higher on Monday but there was little positive news to sustain the opening gains. Biotech stocks traded lower to drag the Nasdaq Composite lower. Heavyweight...
Pharmaceutical giants Merck and Pfizer are both releasing their first quarter financial results early Tuesday.